Prognostic role of p53 in stage III non-small cell lung cancer.
Fiche publication
Journal
Anticancer research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MASCAUX Céline
Tous les auteurs :
Berghmans T, Mascaux C, Martin B, Ninane V, Sculier JP
Lien Pubmed
Résumé
New biological factors have not been extensively studied in stage III non-small cell lung cancer (NSCLC). We aimed to determine the role of p53 as a prognostic factor in such patients.
Mots clés
Adult, Aged, Aged, 80 and over, Biomarkers, Tumor, biosynthesis, Carcinoma, Non-Small-Cell Lung, metabolism, Combined Modality Therapy, Female, Humans, Immunohistochemistry, Lung Neoplasms, metabolism, Male, Middle Aged, Neoplasm Staging, Prognosis, Proportional Hazards Models, Tumor Suppressor Protein p53, biosynthesis
Référence
Anticancer Res.. ;25(3c):2385-9